Guideline title | Organization | Country | Publication year | Target disorders | Aim | For which patient population is this guideline intended for? | For which healthcare provider is this guideline intended for? | Clinical setting for which this is applicable |
---|---|---|---|---|---|---|---|---|
Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings [37] | NICE | UK | 2011 | Psychosis + SUD | To provide diagnosis and treatment recommendations for both disorders. | For all patients above 14 years old with both disorders. | For professionals who provide care in all clinical settings. | All clinical settings and medical services that commissioned by NHS |
Coexisting severe mental illness and substance misuse: community health and social care services overview [38] | NICE | UK | 2016 | Psychosis + SUD | To offer a number of integrated services to meet people’s requirements and solve other related problems, such as lack of housing and joblessness. | For patients above 14 years old with both disorders. | All professionals and commissioners, Workers who have direct contact with patients, The criminal justice system, Voluntary organizations and other third-party sectors, Targeted patients and their families and carers. | Community settings |
Guidelines on the management of cooccurring alcohol and other drug and mental health conditions in alcohol and other drug treatment settings [39] | Australian government | Australia | 2016 | Co-occurring alcohol and other drug and mental health conditions | To provide directives in relation to the management of AOD and co-occurring mental health conditions. | Patients with AOD and co-occurring mental health conditions. | AOD workers, including nurses, medical practitioners, psychiatrists, psychologists, counsellors, social workers, and other AOD workers. | AOD treatment settings |
Management of schizophrenia [47] | SIGN | UK | 2013 | Schizophrenia | To provide recommendations for managing schizophrenia. | Adults with schizophrenia | Healthcare providers | Not mentioned specifically |
Psychosis and schizophrenia in adults: prevention and management [48] | NICE | UK | 2014 | Psychosis and schizophrenia | To provide diagnosis and treatment recommendations psychosis and schizophrenia. | Adults with psychosis and schizophrenia | Health care providers who provide services in primary, community, secondary and tertiary clinical settings. | All clinical settings and medical services that commissioned by NHS |
Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation [49] | WFSBP | International | 2015 | Schizophrenia | To issue guidelines relating to the management of schizophrenia and the assessment of pharmacological agents. | Patients with schizophrenia. | Physicians | Not mentioned specifically |
Clinical practice guidelines for the management of schizophrenia and related disorders [50] | RANZCP | Australia and New Zealand | 2016 | Schizophrenia and related disorders | To provide guidance for the treatment of schizophrenia and to provide care for schizophrenic patients. | For patients with schizophrenia and related disorders. | Clinicians such as psychiatrists and GPs, psychiatry trainees, mental health nurses, clinicians who have contact with this patient group, and policymakers. | Not mentioned specifically |
Evidence-based guidelines for the pharmacological treatment of schizophrenia [51] | BAP | UK | 2019 | Schizophrenia | To provide recommendations for the management of schizophrenia. | Patients with schizophrenia | Clinicians | Not mentioned specifically |
Practice guideline for the treatment of patients with schizophrenia [52] | APA | US | 2020 | Schizophrenia | To help clinicians optimize care for their patients and improve quality of care. | Patients with schizophrenia | Clinicians | Not mentioned specifically |
Management of Bipolar Disorder in Adults (BD) [53] | VA/DoD | US | 2010 | Bipolar disorder | To manage patients with bipolar disorder. | People aged 18 years old and older with bipolar disorder. | Healthcare professionals | Not mentioned specifically |
Bipolar disorder [54] | Singapore MOH | Singapore | 2011 | Bipolar disorder | To manage patients with bipolar disorder. | Older patients with bipolar disorder | GP and clinicians | Not mentioned specifically |
The assessment and management of bipolar disorder in adults, children and young people in primary and secondary care [55] | NICE | UK | 2014 | Bipolar disorders | To manage patients with bipolar disorder. | Children, young adults (aged above 13 years old), and adults. | Professionals who provide care in all clinical settings. | All clinical settings and medical services that commissioned by NHS |
Evidence-based guidelines for treating bipolar disorder [56] | BAP | UK | 2016 | Bipolar disorder | To assess and manage patients with bipolar disorder. | Patients with bipolar disorder. | Practitioners | Not mentioned specifically |
Guidelines for the management of patients with bipolar disorder [57] | CANMAT and ISBD | Canada | 2018 | Bipolar disorder | To manage patients with bipolar disorder. | Patients with bipolar disorder | Psychiatrists and primary care providers | Not mentioned specifically |
Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity [40] | BAP | UK | 2012 | SUD | To provide treatment recommendations in order to help clinicians in prescribing medication for patients with SUD alone and those with psychiatric comorbidities. | Young adults and adults with SUD. | Clinicians such as psychiatrists and GPs, professionals in this field, non-specialists, patients and their families. | Not mentioned specifically |
Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision [41] | WFSBP | International | 2017 | Substance use and related disorders | To provide recommendations for the treatment of AUD that help clinicians in clinical decision making and subsequently improvement of care | Adult with AUD | Professionals who provide care for patients with AUD. | Not mentioned specifically |
Drug misuse and dependence UK guidelines on clinical management [42] | gov.uk | UK | 2017 | Substance misuse | To provide guidance on managing drug abuse and dependency in the UK. | Drug misusers | Healthcare professionals, Regulatory bodies, Targeted patients, and their families and carers. | Drug misuse services |
German Guidelines on Screening, Diagnosis and Treatment of Alcohol Use Disorders [43] | DGPPN and DG-Sucht | Germany | 2017 | Alcohol use disorder | To provide screening, diagnosis, and treatment recommendations for patients with alcohol misuse disorder. | Patients with alcohol misuse disorder and comorbidity psychiatric disorders. | Clinicians | In- and outpatient settings |
Alcohol use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence [44] | NICE | UK | 2011 | Alcohol use disorder | To provide recommendations for managing patients with alcohol misuse disorder. | Younger children and young adults 10–17 years old with alcohol use disorder. | Professionals who provide care in all clinical settings. | All clinical settings and medical services that commissioned by NHS |
Practice guideline for the Pharmacological Treatment of Patients with Alcohol Use Disorder [45] | APA | US | 2018 | Alcohol use disorder | To provide recommendations that help in improving the quality of care and quality of life for patients with AUD. | Patients with AUD | Clinicians | Not mentioned specifically |
National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use [46] | ASAM | US | 2015 | Opioid use disorder | To provide recommendations for managing patients with opioid use disorder. | Patients with opioid use disorder | Physicians; other healthcare providers, medical educators, trainee; and clinical care managers. | Not mentioned specifically |